<DOC>
	<DOCNO>NCT02367716</DOCNO>
	<brief_summary>The purpose clinical study observe safety efficacy multi-vector LV lead Chinese patient indicate Cardiac Resynchronization Therapy ( CRT ) . This multi-center , non-randomized observational study . The total duration study expect 2.5 year . The clinical study conduct 15 center China . Approximately 120 subject enrol study . Subjects follow 3 , 6 , 12months every 6 month afterwards . All subject need follow least 6 month .</brief_summary>
	<brief_title>Post-market Study Multi-Vector LV Lead Performance Chinese Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>• Meets current ESC ACCF/AHA/HRS Class I Class IIa indication CRT implant ( include upgrade single dual chamber ICDs ) Are ≥ 18 year age time enrolment . Are able provide write Informed Consent prior study related procedure . • Patient unable comply followup schedule . Patient medical condition opinion investigator appropriate participate study . Patient life expectancy le 1 year due condition . Patients , CRT device implant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>